Nanoscopic core-shell drug carriers made of amphiphilic triblock and star-diblock copolymers

被引:64
作者
Quaglia, Fabiana
Ostacolo, Luisanna
De Rosa, Giuseppe
La Rotonda, Maria Immacolata
Ammendola, Massimo
Nese, Giuseppe
Maglio, Giovanni
Palumbo, Rosario
Vauthier, Christine
机构
[1] Univ Naples Federico II, Dept Pharmacol & Toxicol Chem, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy
[3] Univ Paris Sud, CNRS, UMR 8612, Lab Physicochim Pharmacotech & Biopharm, F-92296 Chatenay Malabry, France
关键词
nanoparticles; amphiphilic block copolymers; poly(epsilon-caprolactone); poly(ethylene oxide); all-trans-retinoic acid;
D O I
10.1016/j.ijpharm.2006.07.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to design injectable nanocarriers for drug delivery based on PCL-PEO amphiphilic block copolymers with linear ABA triblock and 4-armed (BA)(4) star-diblock architectures (A = PEO, B = PCL). The copolymers were obtained by coupling of a monofunctional -COOH end-capped PEO (M-n = 2.0 kDa) with linear or 4-armed star-shaped PCL macromers bearing -OH terminal groups and were characterized by H-1 NMR spectroscopy and size exclusion chromatography. DSC and X-ray diffraction experiments showed that separate crystalline phases of PCL and PEO are present in bulk copolymers. Nanoparticles were produced by nanoprecipitation (NP) and by a new melting-sonication procedure (MS) without the use of toxic solvents, and characterized for size, polydispersity, zeta potential and core-shell structure. Nanoparticles were loaded with all-traps-retinoic acid (atRA) as a model drug and their release features assessed. Results demonstrate that both techniques allow the formation of PEO-coated nanoparticles with a hydrodynamic diameter that is larger for nanoparticles prepared by MS. atRA is released from nanoparticles at controlled rates depending on size, loading and, more important, preparation technique, being release rate faster for MS nanoparticles. Some biorelevant properties of the carrier such as complement activation were finally explored to predict their circulation time after intravenous injection. It is demonstrated that nanoparticles prepared by MS do not activate complement and are of great interest for future in vivo applications. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 66
页数:11
相关论文
共 27 条
[1]  
[Anonymous], [No title captured]
[2]  
Bhadra D, 2002, PHARMAZIE, V57, P5
[3]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[4]  
COUVREUR P, NANOTECHNOLOGY INTEL
[5]   Nanotechnology and medicine [J].
Emerich, DF ;
Thanos, CG .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (04) :655-663
[6]   'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):: influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption [J].
Gref, R ;
Lück, M ;
Quellec, P ;
Marchand, M ;
Dellacherie, E ;
Harnisch, S ;
Blunk, T ;
Müller, RH .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2000, 18 (3-4) :301-313
[7]   BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES [J].
GREF, R ;
MINAMITAKE, Y ;
PERACCHIA, MT ;
TRUBETSKOY, V ;
TORCHILIN, V ;
LANGER, R .
SCIENCE, 1994, 263 (5153) :1600-1603
[8]   Nanotechnology in clinical laboratory diagnostics [J].
Jain, KK .
CLINICA CHIMICA ACTA, 2005, 358 (1-2) :37-54
[9]   All-trans-retinoic acid release from core-shell type nanoparticles of poly (ε-caprolactone)/poly (ethylene glycol) diblock copolymer [J].
Jeong, YI ;
Kang, MK ;
Sun, HS ;
Kang, SS ;
Kim, HW ;
Moon, KS ;
Lee, KJ ;
Kim, SH ;
Jung, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 273 (1-2) :95-107
[10]   Crystallization and ring-banded spherulite morphology of poly(ethylene oxide)-block-poly(ε-caprolactone) diblock copolymer [J].
Jiang, SC ;
He, CL ;
An, LJ ;
Chen, XS ;
Jiang, BZ .
MACROMOLECULAR CHEMISTRY AND PHYSICS, 2004, 205 (16) :2229-2234